Abstract-Whether or not a given chemical substance is readily biodegradable is an important piece of information in risk screening for both new and existing chemicals. Despite the relatively low cost of Organization for Economic Cooperation and Development tests, data are often unavailable and biodegradability must be estimated. In this paper, we focus on the predictive value of selected Biowin models and model batteries using Bayesian analysis. Posterior probabilities, calculated based on performance with the model training sets using Bayes' theorem, were closely matched by actual performance with an expanded set of 374 premanufacture notice (PMN) substances. Further analysis suggested that a simple battery consisting of Biowin3 (survey ultimate biodegradation model) and Biowin5 (Ministry of International Trade and Industry [MITI] linear model) would have enhanced predictive power in comparison to individual models. Application of the battery to PMN substances showed that performance matched expectation. This approach significantly reduced both false positives for ready biodegradability and the overall misclassification rate. Similar results were obtained for a set of 63 pharmaceuticals using a battery consisting of Biowin3 and Biowin6 (MITI nonlinear model). Biodegradation data for PMNs tested in multiple ready tests or both inherent and ready biodegradation tests yielded additional insights that may be useful in risk screening.
INTRODUCTION
Whether a substance is readily biodegradable (RB) or not readily biodegradable (NRB) may have significant economic and regulatory impact. In the European Union (EU), it is an important factor in classification and labeling under the dangerous substances directive [1] as well as environmental risk assessment [2] . Not readily biodegradable substances that meet ecotoxicity criteria are assigned the R53 risk phrase (''may cause long-term adverse effects in the environment'') and are given a label with pictures of a dead fish and tree. Ready biodegradability is included in the minimum premarket dataset (MPD) that is part of the new substances notification requirements in the EU; and in the United States, it is one of a relatively small number of environmental fate data requirements included in the voluntary High Production Volume Chemical Challenge (HPVC) program. Applications in design and formulation of safer chemical products (green chemistry) are infrequently published, but are probably also numerous.
Whether the objective is to avoid the R53 risk phrase, screen an inventory of existing substances to identify those that warrant further scrutiny, or compare candidate substances in product development, it is useful to have some idea of the probability that a substance is RB or NRB before making a decision about testing. It is generally assumed that computer models can be useful in this regard. A substantial number have been developed that require only chemical structure as input, and these have been subjected to varying types of validation. In previous work we showed that several of the Biowin models could be used to estimate ready biodegradability for a set of highly diverse substances, RB, and NRB substances being classified with comparable accuracy [3] .
It can be argued that a more important piece of information for the assessor is the probability that a given untested substance is RB or NRB. Bayes' theorem [4] , commonly used in epidemiology but infrequently in environmental science, provides the appropriate mathematical framework for making this determination. As demonstrated previously [5] , the predictive value of individual models can be estimated by using Bayes' theorem to calculate posterior probabilities for RB/NRB, based on data for each model's training set. Models can then be combined in batteries to enhance predictive power and reduce the potential for misclassification. This approach was recently applied to a three-model battery consisting of CATABOL, Biowin1 (linear biodegradation probability model) (Syracuse Research, Syracuse, NY, USA), and Biowin2 (nonlinear biodegradation probability model) to lower the number of false positives and false negatives for classification of a set of 63 pharmaceuticals (McDowell RM, Jaworska JS. Bayesian battery approach: Application to predicting biodegradability. Poster presentation at SETAC Europe meeting, Vienna, Austria, May 2002) .
In the present work we extended these methods to Biowin3 (survey ultimate biodegradation model), Biowin5 (Ministry of International Trade and Industry [MITI] linear model), and Biowin6 (MITI nonlinear model), comparing predictive value (posterior probabilities) to actual performance with an expanded set of premanufacture notice (PMN) substances and the set of pharmaceuticals. Biowin 3 also was validated using a set of existing substances with ready biodegradation data from the MITI-I (301C) test. Test battery approaches were explored by applying Bayes' theorem to calculate joint posterior probabilities for RB/NRB [5] . Results show that twomodel batteries consisting of Biowin3 and Biowin5 or 6 have enhanced predictive power in comparison to the individual models.
METHODS AND MATERIALS

Biodegradation data for PMN substances
No automatic requirement exists for testing of new substances under the U.S. Toxic Substances Control Act [6] The set of 374 substances was carefully reviewed to ensure that the data met the requirements for a ready test [7] . In addition, the PMN database was restricted to structures with molecular weight (MW) Ͻ 800. This eliminated a small number of large structures that were difficult to enter into computer models.
The OECD pass criteria for ready biodegradability are 70% for tests based on dissolved organic carbon (DOC) and 60% for tests based on oxygen uptake or CO 2 production [7] . For this work, the 70% criterion for DOC tests was retained but 50% was used for the other tests [8] [9] [10] [11] ; and the 10-d window criterion was not applied [12] .
MITI biodegradation data
The so-called MITI data for existing chemicals have been used to develop many different models for predicting biodegradability at the screening level [13] [14] [15] [16] . These data can be downloaded individually from a website maintained by the Chemical Evaluation and Research Institute (CERI), Japan (http://www.cerij.or.jp/cerien/otoiawasemenu.html). Unfortunately, the provenance of the data used in model development is poorly or not characterized in many of the published works, so it is important to download data from its original source. We started with a file containing only the RB/NRB designation for 929 existing substances (H. Loonen, Villa Fayence, Chemin des Escassiers, La Bouilladisse, France, personal communication). The CERI website was then queried for each of these substances to retrieve missing data such as the percentage of theoretical oxygen demand (ThOD), test duration, etcetera. The 921 substances in this file were then scrutinized to yield a set of 398 substances, as follows: Initial data set, n ϭ 921, delete substances with no data in BOD field (n ϭ 291); → n ϭ 630, delete substances with Ͻ 50% ThOD in Ͻ 28-d test (n ϭ 169); → n ϭ 461, delete substances with sludge concentration Ն 100 mg/L (n ϭ 17); → n ϭ 444, delete substances with Ͼ 20% difference between any two replicate biochemical oxygen demand (BOD) values (n ϭ 44); → nϭ400, delete substances with 0 mg/L entered in the concentration field (nϭ2); → n ϭ 398.
Rationale for each step: Judgment of RB or NRB cannot be made without the actual data, especially if a different pass criterion is used; there is no way to tell in such a case whether the test substance might have passed had the test been run for the full duration; sludge concentrations Ն 100 mg/L are too high (test is too vigorous) to meet the conditions of a ready test; the OECD [7] states that if any two replicate values differ by more than 20%, the test should be repeated; data are suspect.
Pharmaceutical agents with ready biodegradation data
Ready biodegradability data were retrieved from the literature for 63 pharmaceutical agents (Table 1 ). Only one test was available for the majority of the compounds, and for more than one-third (mostly compounds listed in Richardson and Bowron [17] neither an actual value for percent degradation nor the test method was given in the original source. This precluded checking the data for quality as was done for PMN and MITI substances.
Bayesian analysis
In Bayesian analysis, performance statistics, called likelihood values, are calculated for the model being considered, then combined with prior probability in Bayes' formula to generate posterior probabilities. The likelihood statistics are more commonly referred to as sensitivity and specificity, which are simply the percent correctly classified, for a given model, for substances in that model's training set that had positive and negative test results, respectively. Posterior probabilities also are referred to as predictive value positive and predictive value negative, which denote the probability that an object (chemical substance in this case) either has an attribute (is RB), given that it predicted to be RB, or lacks the attribute (is NRB), given that the model predicts NRB. For this study, false positives are substances predicted to be RB but that test NRB, and false negatives are substances predicted to be NRB but that test RB. Posterior probabilities are the correct statistics for making inferences about untested objects.
In practice, spreadsheet programs are used to make Bayesian calculations, especially where the objective is to determine posterior probabilities for classification by model batteries, as opposed to individual models. An Excel (Microsoft, Redmond, WA, USA) spreadsheet program convenient for Bayesian analysis of one-, two-, or three-stage classification procedures is available from the authors (jaworska.j@pg.com).
The critical inputs for Bayesian analysis are the sensitivity and specificity of each model under consideration and the prior probability selected for the analysis. By definition, the prior probability of RB/NRB is the relative frequency of RB/NRB substances (as determined by actual testing) in a population of substances. For PMN substances, the prior probability of RB therefore is 96/374 ϭ 0.26, and for NRB the value is 278/ 374 ϭ 0.74. For pharmaceuticals, the prior probability of RB is 10/63 ϭ 0.16. Sensitivity and specificity are given in Table  2 for Biowin3, 5, and 6. For Biowin5 and 6, sensitivity and specificity are equivalent to published values of percent correctly classified for RB and NRB substances in the Biowin5/6 training set [16] . For Biowin3 it is less obvious what the values should be, because the training set for that model consisted of semiquantitative estimates of biodegradability from a panel of experts [18] a PMN ϭ premanufacture notice; Sens ϭ sensitivity; Spec ϭ specificity; RB ϭ Readily biodegradable; NRB ϭ not readily biodegradable. Biowin address: Syracuse Research (Syracuse, NY, USA). b Probability that a substance is RB given that it is estimated to be RB. c Probability that a substance is NRB given that it is estimated to be NRB.
ready biodegradability was not a consideration. However, given that time for complete aerobic ultimate biodegradation in surface waters was the endpoint for which the 200 survey substances were rated by the experts, and that OECD ready tests are 28-d tests designed to (very crudely) represent surface waters, it seemed reasonable to use weeks as the classification criterion. Therefore, sensitivity and specificity were determined by first assigning to each substance in the training set either RB or NRB depending on whether the expert biodegradability estimate was weeks, or faster versus slower than weeks, and then comparing these to the Biowin3 predictions.
Cluster analysis
Hierarchical cluster analysis was performed using the default settings of QSARIS Ver 2.1 (Molecular Design Limited, San Leandro, CA, USA). The analysis used Ward's method (Euclidean distance) and the complete set of built-in descriptors: E-state indices and atom counts; connectivity indices; hydrogen electrotopological state (HE-state) categories and groups; internal H-bond E-states; Kappa shape indices; log K OW ; total topological indices; 3-dimensional descriptors; and molecular properties. The resulting cluster analysis for the MITI and PMN data sets selected 194 and 205 descriptors, respectively. For presentation purposes, 25 clusters were displayed for the plots, resulting in a linkage distance of 811.3 for the MITI data set and 669.4 for the PMN data set. The cumulative percent of variance for the principal components analysis data scores (t1, t2, t3, t4) were 39.88 for the MITI data set and 44.25 for the PMN data set.
Software
Biodegradation estimates were obtained using the Biowin module of Epiwin Ver 3.10, U.S. EPA version for Microsoft Windows (Microsoft). Epiwin essentially is the same as EpiSuite, which is available for free download at http:// www.epa.gov/opptintr/exposure/docs/episuite.htm. Bayesian analysis was performed using Microsoft Excel 978 SR-1. Excel files containing chemical structures (as simplified molecular information and line entry system strings) and biodegradation plus other data for the 398-substance quality-checked MITI data set, the 63 pharmaceuticals, and the 200 substances included in the original training set for Biowin3 [18] , are available from the authors (boethling.bob@epa.gov).
RESULTS
PMN versus MITI substances
Substances in the PMN data set (n ϭ 374) are both larger and more complex on average than existing substances, using the MITI data set (n ϭ 398) as a benchmark for the latter. For PMNs average and median molecular weights were 375 and 350, respectively, and for the MITI substances the corresponding values were 189 and 162. For the 63 pharmaceuticals the average and median molecular weights were 365 and 280, respectively.
Chemical structure is almost always designated confidential business information and therefore cannot be revealed for PMN substances. Nevertheless, the greater complexity of PMN substances can be demonstrated using hierarchical cluster analysis as shown in Figure 1 for the PMN and MITI data sets. Cluster analysis is a good method for visualizing the structural diversity among different data sets [19] . Hierarchical clustering methods produce small clusters of similar structures nested within larger clusters of more diverse structures. The similarity of molecules is defined mathematically using distance terms in the 3-D space of molecular descriptors. Point size in Figure  1 relates to the z-axis (larger points are closer to the reader), and colors were selected arbitrarily to highlight 25 different clusters for presentation purposes. For the MITI data set (Fig.  1A) , points of the same color are closer to one another and nearer the origin, whereas for the PMN data set (Fig. 1B) , they are more spread out in 3-D space. This is consistent with general observation, namely that the substances in the PMN data set are more architecturally diverse and contain a wider variety of functional groups than those in the MITI data set.
Among the 374 PMN substances with ready biodegradation data were 13 that had results from two or more different tests. Table 3 presents the test data for this group of substances. Using as pass criteria for RB/NRB the values 50% for BODand CO 2 -based tests and 70% for DOC-based tests, only one substance (MW 579) had multiple test results that appeared contradictory. Similarly, 21 PMN substances had data from both ready and inherent biodegradation tests. Among inherent tests Zahn-Wellens (OECD 302B) was the most frequently performed (11 substances). Figure 2 is a graph of percent degradation in the inherent test versus percent degradation in the ready test for the 21 substances, and shows that the test results for ready and inherent biodegradation correlated quite well (correlation coefficient ϭ 0.94, excluding one substance). , n ϭ 374). Point size relates to the z-axis (larger points are closer to the reader); colors were arbitrarily selected to highlight 25 different clusters for presentation purposes. 
Validation of Biowin models using PMN data
The PMN data set contained 96 RB and 278 NRB substances. Although Biowin3 expresses biodegradability using terms like days and weeks, the model algorithm is actually a multiple linear regression with a library of molecular fragments plus MW as the independent variables, and model output is a number between 1 and 5. To determine the optimum value for RB/NRB classification of PMN substances, we calculated percent correctly classified for RB, NRB, and all PMN substances as a function of the numerical classification criterion. As shown in Figure 3 , the cutoff currently used in Biowin3 to differentiate between weeks and weeks to months (the value is 2.75 and is transparent to model users) is optimum for this model and data set. Percent correctly classified for Biowin3, 5, and 6 (Table 4 ) are similar to values previously reported for a somewhat smaller data set [3] .
Insufficient data were available for a comparison of Biowin3 predictions for all individual test methods, but results are shown in Table 4 for PMN substances tested using the Sturm Method (OECD 301B; n ϭ 153) and the two most popular test methods based on biochemical oxygen demand (BOD), the MITI-I test (OECD 301C) and the closed bottle test (OECD 301D) (n ϭ 142 for 301C and 301D tests combined). Biowin3 accuracy for the subset of Sturm tests was comparable to that for the entire database, but accuracy was higher for the two BOD tests, which generally are considered more stringent [20] .
As a more severe test of model performance, PMN substances with MW Ͼ 500 were temporarily removed from the validation set and classification accuracy was reassessed for the remaining PMN substances (n ϭ 277). This should decrease overall accuracy because the largest substances are mostly NRB and are likely to be estimated as such by the Biowin models, which in addition to molecular fragments have MW as an independent variable. Of the 97 substances with 500 Ͻ MW Ͻ 800, 89 were NRB but only eight were RB. However, overall accuracy did not decline drastically for any of the models (Table 4) .
Validation of Biowin3 using MITI data
Biowin3 also was validated using a carefully checked file of existing substances with data from the CERI website (MITI substances). Analysis of percent correctly classified versus Biowin3 classification criterion for the 398 MITI substances (RB ϭ 187; NRB ϭ 211) showed that the optimum value for these data was 2.85. Results in Table 4 for the MITI data were derived using this value and indicate that accuracy was approximately 80% for both RB and NRB substances. Nearly identical results were reported for the Biowin5 and 6 training and validation sets [16] , which also consisted of MITI substances.
Predictive value of Biowin models
Posterior probabilities for RB/NRB from Biowin3, 5, and 6 are given in Table 2 together with sensitivity, specificity, and prior probabilities. Actual performance statistics for Biowin 3, 5, and 6 with the 374 PMN substances, expressed in terms of percentages of RB and NRB predictions that were correct, were quite close to the posterior probabilities. Table  5 presents numbers of false positive (FP), false negative (FN), and total misclassified substances for the PMN and pharmaceutical data sets. False positive generally exceeded FN for individual models.
Using model batteries to increase predictive value
We sought to increase the predictive value of the individual Biowin models by using model batteries. Using a battery, RB/ NRB classification is based on the joint posterior probability. Posterior probabilities for a battery consisting of Biowin3 and 5 are shown in Table 6 . If both models return a prediction of RB for a substance, the probability of that substance testing RB is estimated to be 0.89. Similarly, if both models predict NRB for the substance, the probability of the substance being NRB is calculated to be 0.98. Thus where the two models agree, the level of certainty is considerably higher than is the case for any individual model (Table 2 ). If one model predicts RB but the other NRB, the probability of the substance being R.S. Boethling et al. NRB is approximately 0.7 regardless of which model gives RB and which NRB. The distribution of measured RB/NRB for the 374 PMN substances was consistent with the posterior probabilities ( Table 6 ). This battery reduced the number of misclassified substances (44 total out of 374) relative to results for individual models, including a substantial reduction in the proportion of FP (Table 5) .
Similar results were obtained for the 63 pharmaceuticals with ready biodegradation data ( Table 7) . For Biowin3 the classification criterion was 2.85, as for the MITI data. A battery consisting of Biowin3 and Biowin6 reduced the number of misclassified substances to 7 out of 63, with only one FP ( Table  5 ). Actual battery predictions for the 63 pharmaceuticals are in Table 1 .
To illustrate application of batteries to specific substances, Table 3 compares posterior probabilities to actual test results for a subset of the PMN substances. The results show that the posterior probability of a substance being RB does tend to become more polarized at 0 or 1 with increasing information (addition of more models).
DISCUSSION
The Biowin models provide good accuracy in predicting ready biodegradability. Biowin3 (survey ultimate biodegradation model) performed best with 374 PMN substances, with 86% accuracy for both RB and NRB substances. Biowin3 also classified substances from the Japanese CERI database (i.e., the MITI substances) with 80% accuracy (Table 4) . For the subset of PMN substances tested in the two most stringent tests [20] , closed bottle (301D) and MITI-I (301C), accuracy reached 90%. Both PMN and MITI substances are highly diverse in molecular structure and size, but cluster analysis suggests greater complexity for PMN substances. For the pharmaceuticals, Biowin5 and 6 were more accurate than Biowin3 in predicting ready biodegradability, with 82.5% (52/63), 87.3% (55/63), and 76.2% (48/63) correctly classified, respectively.
Ultimately, the most useful knowledge for chemical screening may be the probability that a given model prediction is correct. From this perspective, it is important that even though the Biowin models were comparably accurate with RB and NRB substances for the PMN data set, RB predictions were considerably less likely to be correct (Table 2 ). This means that FP outnumbered FN (Table 5 ). Obviously it is desirable to minimize the total number of misclassified substances (FP ϩ FN), but preference should be given to reducing FP over FN, assuming it is preferable to diminish the potential for negative environmental consequences that may result from approving a substance that turns out to be nonbiodegradable. This situation is the reverse of others that may be more familiar, e.g., human immunodeficiency virus (HIV) screening where in contrast to ready biodegradability the trait of interest (being positive for HIV) is undesirable, and false negatives are the high-consequence events [5] .
Bayesian analysis provides the appropriate mathematical framework for making inferences about unknown objects, and in addition, as we have shown here and previously (McDowell RM, Jaworska JS. Bayesian battery approach: Application to predicting biodegradability. Poster presentation at SETAC Europe meeting, Vienna, Austria, May 2002), can be applied to batteries of models for predicting ready biodegradability. It has been used most extensively in epidemiology and clinical medicine, where the objective is to understand (make statistically precise statements about) the probability that an object or system does or does not have a certain characteristic, depending on the outcome of one or more diagnostic procedures. It is equally applicable to other problems in classification [5] , including situations in which structure/activity relationships rather than diagnostic tests are used to assign a substance to one class or another.
In Bayesian analysis, posterior probabilities express predictive value, and are the appropriate statistics for inferring from model results the probability that the next substance is RB or NRB. We found that the posterior probabilities for application of Biowin3, 5, and 6 to PMN substances matched quite well the actual performance of the models, as expressed by percent of RB and NRB predictions that were correct for the 374 PMN substances (Table 2 ). In Bayesian calculations for batteries of models, the posterior probabilities for the first model are used as the prior probabilities for the next model, and are processed through Bayes' formula to yield joint posterior probabilities for application of the two-model battery to the given population of objects (substances). A third model can be added in the same fashion (posteriors from second model become priors for third model), and a fourth, and so on. We found that posterior probabilities for two-model batteries also were consistent with results from actual application to PMN substances and pharmaceuticals (Tables 6 and 7) .
It is important to note that posterior probabilities are calculated without running any model for any validation set. The only inputs for Bayesian analysis are the sensitivity and specificity that pertain to a model's training set, and the prior probabilities, which are the proportions of substances that actually tested RB and NRB for a given validation set. Overall, the results suggest that a good strategy for predicting ready biodegradability of PMN substances is to use a simple battery consisting of Biowin3 and 5. For pharmaceuticals the battery consisting of Biowin3 and 6 yielded slightly better results. In either case, the battery prediction for any substance is RB only if both models yield RB.
Analysis by chemical structure of substances whose ready biodegradability was incorrectly predicted by model batteries was mostly beyond the scope of this work. In general, poorly predicted PMN substances tended to confirm findings reported earlier for the individual models [3, 16, 18] . These include, for example, a tendency for FP resulting from inadequate parameterization of the Biowin models for cycloaliphatics and Nheterocyclics [3] . It also bears repeating that because there are many ways for a substance to fail a ready test given the tests' stringency, many FP may actually reflect incorrect test results. The poorly predicted pharmaceuticals are interesting in that of the six FN (7, 9, 19, 30 , 47, and 57 in Table 1 ), most are natural products or derivatives. These include caffeine (9), dihydroergotamine (19) , menthol (30) , and theophylline (57). It seems obvious that structural proximity to natural products ought to be important in determining biodegradability, but Biowin has no way to make such a determination. Biowin also cannot differentiate between D and L forms of a sugar, as shown by the battery results for the two antineoplastic mustards (7 and 8) .
Finally, biodegradation data for PMN substances tested in multiple ready tests or both inherent and ready biodegradation tests yielded additional insights that may be useful in risk screening. In the first case, much has been made of the high variability of ready tests both within and between labs (e.g., see Gerike and Fischer [21] , Howard et al. [22] , and most recently, Painter et al. [11] ). However, we found the correlation for paired results from different tests to be quite good. Similarly, results from inherent and ready biodegradability tests for a different set of 21 substances were well correlated especially for the Zahn-Wellens and MITI-II tests. Except for one substance, no substance that failed a ready test (12 of 20) achieved more than 48% degradation in any inherent test. The exception was a dialkyl quaternary ammonium surfactant that showed behavior typical of this class [23] : Relatively high removal due to sorption (64%) in a semicontinuous activated sludge (SCAS) test, but no degradation in a ready (Sturm) test. The correlation between ready and inherent test results is surprising because supposedly, inherent tests have much more favorable conditions than do ready tests, and ''are designed to assess whether the chemical has any potential for biodegradation'' [24, 25] . Although both comparisons are based on limited data, the selection of substances should be unbiased. These results would seem to enhance the credibility of ready tests in chemical assessment while questioning the value of inherent tests.
CONCLUSION
The Biowin models provide good accuracy in predicting ready biodegradability. Biowin3 was especially good for PMN substances tested in the stringent closed bottle (301D) and MITI-I (301C) tests. The predictive value of selected Biowin models, calculated from information about the model training sets using Bayes' formula, matched model performance in classifying a large and highly diverse set of chemical (PMN) substances for ready biodegradability. The predictive value calculated for model batteries (Biowin3 and 5/6) also matched performance with validation sets. Use of the batteries signif-
